These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 28219721)

  • 41. Impact of surface grafting density of PEG macromolecules on dually fluorescent silica nanoparticles used for the in vivo imaging of subcutaneous tumors.
    Adumeau L; Genevois C; Roudier L; Schatz C; Couillaud F; Mornet S
    Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1587-1596. PubMed ID: 28179102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dendrimer-nanoparticle conjugates in nanomedicine.
    Parat A; Bordeianu C; Dib H; Garofalo A; Walter A; Bégin-Colin S; Felder-Flesch D
    Nanomedicine (Lond); 2015; 10(6):977-92. PubMed ID: 25867861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of magnetic nanoparticles in cancer theranostics: Toward handheld diagnostic devices.
    Hajba L; Guttman A
    Biotechnol Adv; 2016; 34(4):354-361. PubMed ID: 26853617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A review on the role of lipid-based nanoparticles in medical diagnosis and imaging.
    Mirahadi M; Ghanbarzadeh S; Ghorbani M; Gholizadeh A; Hamishehkar H
    Ther Deliv; 2018 Aug; 9(8):557-569. PubMed ID: 30071803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Triple Hit with Drug Carriers: pH- and Temperature-Responsive Theranostics for Multimodal Chemo- and Photothermal Therapy and Diagnostic Applications.
    Baek S; Singh RK; Kim TH; Seo JW; Shin US; Chrzanowski W; Kim HW
    ACS Appl Mater Interfaces; 2016 Apr; 8(14):8967-79. PubMed ID: 26926826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Supramolecular Agents for Theranostics].
    Deyev SM; Lebedenko EN
    Bioorg Khim; 2015; 41(5):539-52. PubMed ID: 26762091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent Developments of Magnetic Nanoparticles for Theranostics of Brain Tumor.
    Shevtsov M; Multhoff G
    Curr Drug Metab; 2016; 17(8):737-744. PubMed ID: 27280470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
    Hou L; Shan X; Hao L; Feng Q; Zhang Z
    Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Smart Delivery Systems Based on Poly(glycidyl methacrylate)s-Coated Organic/Inorganic Core-Shell Nanohybrids.
    Tan LL; Shang L
    Macromol Rapid Commun; 2019 Sep; 40(17):e1800879. PubMed ID: 30817069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Doxorubicin-Loaded Unimolecular Micelle-Stabilized Gold Nanoparticles as a Theranostic Nanoplatform for Tumor-Targeted Chemotherapy and Computed Tomography Imaging.
    Lin W; Zhang X; Qian L; Yao N; Pan Y; Zhang L
    Biomacromolecules; 2017 Dec; 18(12):3869-3880. PubMed ID: 29032674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
    Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
    Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Magnetic nanoparticles in biomedicine: synthesis, functionalization and applications.
    Frimpong RA; Hilt JZ
    Nanomedicine (Lond); 2010 Nov; 5(9):1401-14. PubMed ID: 21128722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nanosystem composed with MSNs, gadolinium, liposome and cytotoxic peptides for tumor theranostics.
    Jin Y; Zhang N; Li C; Pu K; Ding C; Zhu Y
    Colloids Surf B Biointerfaces; 2017 Mar; 151():240-248. PubMed ID: 28024200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimuli-responsive poly(N-isopropyl acrylamide)-co-tyrosine@gadolinium: Iron oxide nanoparticle-based nanotheranostic for cancer diagnosis and treatment.
    Roy E; Patra S; Madhuri R; Sharma PK
    Colloids Surf B Biointerfaces; 2016 Jun; 142():248-258. PubMed ID: 26962761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protease-activated nanomaterials for targeted cancer theranostics.
    Chan YC; Hsiao M
    Nanomedicine (Lond); 2017 Sep; 12(18):2153-2159. PubMed ID: 28814163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Magnetic mediators for ultrasound theranostics.
    Józefczak A; Kaczmarek K; Bielas R
    Theranostics; 2021; 11(20):10091-10113. PubMed ID: 34815806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review.
    Indoria S; Singh V; Hsieh MF
    Int J Pharm; 2020 May; 582():119314. PubMed ID: 32283197
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Smart materials on the way to theranostic nanorobots: Molecular machines and nanomotors, advanced biosensors, and intelligent vehicles for drug delivery.
    Sokolov IL; Cherkasov VR; Tregubov AA; Buiucli SR; Nikitin MP
    Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1530-1544. PubMed ID: 28130158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.
    Baek S; Singh RK; Khanal D; Patel KD; Lee EJ; Leong KW; Chrzanowski W; Kim HW
    Nanoscale; 2015 Sep; 7(34):14191-216. PubMed ID: 26260245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.